Toro, L.; Michea, L.; Parra-Lucares, A.; Mendez-Valdes, G.; Villa, E.; Bravo, I.; Pumarino, C.; Ayala, P.; Sanhueza, M.E.; Torres, R.;
et al. High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort. Toxins 2023, 15, 97.
https://doi.org/10.3390/toxins15020097
AMA Style
Toro L, Michea L, Parra-Lucares A, Mendez-Valdes G, Villa E, Bravo I, Pumarino C, Ayala P, Sanhueza ME, Torres R,
et al. High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort. Toxins. 2023; 15(2):97.
https://doi.org/10.3390/toxins15020097
Chicago/Turabian Style
Toro, Luis, Luis Michea, Alfredo Parra-Lucares, Gabriel Mendez-Valdes, Eduardo Villa, Ignacio Bravo, Catalina Pumarino, Patricia Ayala, MarÃa Eugenia Sanhueza, Ruben Torres,
and et al. 2023. "High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort" Toxins 15, no. 2: 97.
https://doi.org/10.3390/toxins15020097
APA Style
Toro, L., Michea, L., Parra-Lucares, A., Mendez-Valdes, G., Villa, E., Bravo, I., Pumarino, C., Ayala, P., Sanhueza, M. E., Torres, R., Elgueta, L., Chavez, S., Rojas, V., & Alvo, M.
(2023). High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort. Toxins, 15(2), 97.
https://doi.org/10.3390/toxins15020097
